433 Current news

rss
matching the following criteria

Polyplus-transfection and the National Institute of Health sign a research license agreement

19-02-2014

Polyplus-transfection SA announces that it has granted two agencies of the United States National Institutes of Health (“NIH”) a non-exclusive, research license to use Polyethylenimine (PEI) for in vitro transfection applications. The two agencies are the National Institute of Allergy and ...

more

MolecularHealth Partners with GATC Biotech for Genetic Sequencing Technology and Expertise

14-01-2014

MolecularHealth announced a unique agreement with GATC Biotech. GATC Biotech will provide protocols, support and extensive training of MolecularHealth’s laboratory staff. Additionally, MolecularHealth will use GATC Biotech’s LIMS (Laboratory Information Management System) in itsnewly opened ...

more

Lonza signs exclusive agreement with Index Ventures

Five year agreement includes all companies where Index Ventures will be the majority shareholder

13-01-2014

Lonza and Index Ventures, LLP announced an exclusive agreement for process development and cGMP production for all biological products in the portfolio of companies where Index is the major investor. Over the course of the agreement, additional development and manufacturing projects will be added ...

more

Evonik and LanzaTech working on bio-processed precursors for specialty plastics

11-12-2013

Evonik Industries and LanzaTech have signed a three year research cooperationagreement which will see Evonik combining its existing biotechnology platforms with LanzaTech’s synthetic biology and gas fermentation expertise for the development of a route to bioprocessed precursors for specialty ...

more

Roche and Molecular Partners enter into alliance

Partnership will combine novel biologics (DARPins) with Roche drug-conjugate technology

05-12-2013

Roche and Molecular Partners AG announced that they have entered into a research collaboration and licensing agreement to discover, develop and commercialize several proprietary therapeutics incorporating Molecular Partners’ DARPin® biologics conjugated to toxic agents developed at Roche for the ...

more

Epigenomics and BioChain enter into collaboration in China

29-10-2013

Epigenomics AG and BioChain announced that the companies have signed an agreement regarding a broad strategic collaboration of both companies. In addition, BioChain will acquire 217,935 newly issued shares of the company which corresponds to an investment of US$ 1.3m (EUR 0.94m) into ...

more

Merck Serono and Selvita announce research collaboration in cancer

28-10-2013

Merck Serono and Selvita announced that they have entered into a collaboration to jointly discover small molecule based drugs targeting proteins involved in cancer cell metabolism. The partners plan to target key metabolic pathways involved in sustaining growth and proliferation of cancer ...

more

Biotechnology for soaking and liming

14-08-2013

The X-Zyme process launched by LANXESS is a technology for the beamhouse stage of the leather production process. “The use of two microbial enzymes in the soaking and liming noticeably improves the quality of the pelt, reduces the amount of waste and makes the entire process much more efficient,” ...

more

Teva and Lonza announce to discontinue Biologics Joint Venture

29-07-2013

Teva Pharmaceutical Industries and Lonza Group announced that following a strategic review of the Teva-Lonza Joint Venture (TL-JV), the companies have decided to discontinue their collaboration for the development, manufacturing and marketing of biosimilars. The discontinuation of the TL-JV, ...

more

Analytik Jena subsidiary obtained approval for two ELISA-based tests for detection of PRRSV

01-07-2013

AJ Roboscreen recently obtained the approval for two new assays for screening of swine sera for PRRSV (porcine reproductive and respiratory syndrome virus) antibodies and for evaluation. The new ELISA-based tests differentiate into PRRSV Type I (Europe-Type) and Type II (North America-Type). The ...

more

Page 1 From 44
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE